Stories from people navigating medication safety — diagnosis, treatment, caregiving, and the ordinary days in between.
5 stories
Clinical Briefs
One recalled lot labeled as 0.9% sodium chloride injection may expose patients to concentrated potassium chloride. Hospitals, pharmacies and infusion services should rapidly isolate affected inventory and trace possible use.
Rayan Salih · October 7, 2026 · 6 min
Health Policy
An FDA Class I recall covers single-shot epidural and epidural/pain kits containing sodium chloride injection ampules, requiring kit-level quarantine and case planning.
Rayan Salih · 6 min read
Clinical Briefs
Par Health recalled two lots of dexmedetomidine injection over particulate matter. Hospitals should trace inventory, replace affected infusions and assess exposed patients.
Rayan Salih · 7 min read
Clinical Briefs
A nationwide recall of 0.9% sodium chloride injection requires US hospitals, pharmacies and infusion services to quarantine affected lots and coordinate safe replacement supply.
Dr. Abu Bakar · 6 min read
Clinical Briefs
An FDA-posted recall covers an affected lot of tocilizumab-aazg (Tyenne) vials because of possible glass particles. Clinicians should separate patient assessment from inventory control.
Rayan Salih · 6 min read
Other conditions
One story a day
One health journey each morning — no advice, no alarm, just company for the road.